PMA P160041S022

Device
Cobas CMV
Applicant
Roche Molecular Systems, Inc.
PMA number
P160041
Supplement
S022
Product code
PAB
Decision date
2019-06-06
Classification
Cytomegalovirus (cmv) Dna Quantitative Assay
Generic name
Cytomegalovirus (cmv) dna quantitative assay
Approval order statement
Scale up for manufacturing of a sub-bulk reagent and subsequent changes to filling operations for a critical component.

Current openFDA PMA Record#

Device
Cobas CMV
Applicant
Roche Molecular Systems, Inc.
PMA number
P160041
Supplement
S022
Product code
PAB
Generic name
Cytomegalovirus (cmv) dna quantitative assay
Decision date
2019-06-06
Decision code
OK30
Date received
2019-05-09
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Scale up for manufacturing of a sub-bulk reagent and subsequent changes to filling operations for a critical component.